Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm

Figure 1

Bone marrow biopsy showing a hypercellular marrow with marked myeloid hyperplasia with left shift ((a) hematoxylin and eosin stain, 400x) and grade 3 fibrosis ((b) reticulin stain, 200x).

(a)

(b)